A direct-to-consumer house of health brands, built on original formulations and honest stories.
Above: the Pineapple wordmark and its supplement-capsule motif. Photographed as a studio still - the fruit that became the brand. Assets: pineapple.co
Most supplement companies begin with a bottle. Pineapple Products began with a classroom. In 2011, the business now run out of San Antonio, Texas, was two people hosting educational health seminars in New York City - no product, no shelf, just an audience and a lesson. More than a decade later, that instinct still defines it: Pineapple is less a single brand than a workshop for building them, a parent company that formulates products, wraps them in a story, and sends each out under its own name.
The founder, Brett Allcorn, describes the throughline plainly. Pineapple exists to "create innovative health supplements and brands combined with strong partnerships and unique stories." That sentence carries more weight than it first appears. In an industry where the shelf is crowded and the ingredients are often interchangeable, Pineapple's wager is that the brand, the narrative, and the partner behind a product are what actually move a customer - and that those things can be built deliberately, one launch at a time.
The figures describe a company that has stayed intentionally small while its ambitions scaled. Employee counts reported across public sources range from roughly 18 to 40, reflecting a remote-first team distributed across North America rather than a single crowded headquarters. What the numbers do agree on is the trajectory: steady growth, external capital, and a portfolio wide enough to keep the lights on across several brands at once.
At its core, Pineapple Products is a direct-to-consumer, e-commerce supplement company that operates a family of brands. "These products might appear under different brand names," the company explains, "but Pineapple is the parent company that creates, markets and oversees them." Each brand gets its own identity and audience; Pineapple provides the formulation, the marketing engine, and the operational spine behind the curtain.
The categories have shifted over time - from online education to men's health, and then to probiotics engineered with unique bacterial strains aimed at metabolism and digestive health. The connective tissue is a single rule the company sets for itself: build products it believes don't already exist. That filter keeps the portfolio from becoming a shelf of me-too bottles.
Pineapple's customers are everyday consumers shopping online for health and wellness - people looking for a probiotic that promises something specific, a digestive or metabolic aid, or a men's health product they can trust. Because Pineapple sells direct, it owns the relationship end to end: the ad that catches attention, the story that earns belief, and the checkout that closes the loop.
The problem it sets out to solve is less about chemistry than about confidence. Supplements are a category thick with skepticism, thin on differentiation, and heavy on claims. Pineapple's answer is to attach real people - doctors, personalities, influencers with an authentic reason to care - to each product, so a purchase feels less like a gamble and more like following someone you already trust.
Plenty of companies sell probiotics. What separates Pineapple is the order of operations. Where a typical brand starts with an ingredient and hunts for an audience, Pineapple starts with a story and a partner, then builds the product to match. That inversion shows up in the details: proprietary strains rather than off-the-shelf blends, brands designed around a person's credibility, and marketing that leans on partnership rather than raw ad spend.
It also explains the company's media footprint. Pineapple's products and events have surfaced in the New York Times, on CNN, NBC, CBS, ABC, the NY Post, MSN and AM New York - coverage that reads less like advertising and more like earned attention. For a business built on believability, a full-page news story is worth more than a banner ad, and Pineapple has structured itself to keep earning them.
The lineup has evolved across four eras - education, men's health, probiotics, and the mature house-of-brands operation that ties them together. Each phase added a capability the next one leaned on.
In-person educational seminars in New York City - the company's first product was knowledge, not a bottle.
The seminars moved online, turning classroom health education into scalable e-learning.
Pineapple entered the supplement market directly, launching its first men's health products.
Supplements built around unique bacterial strains aimed at supporting metabolism and digestive health.
A parent-company engine that formulates, markets and oversees multiple consumer brands at once.
Revenue comes from online product sales spread across the brand portfolio. The direct-to-consumer structure means Pineapple captures the full margin between formulation and customer, and reinvests it into the next launch. Partnership marketing - collaborations with doctors, personalities and influencers - lowers the cost of building trust for each new brand, because the partner brings an audience and a story with them.
Brett Allcorn studied business at NYU's Stern School and product design at Parsons School of Design - a pairing that reads directly onto the company. Stern supplies the spreadsheet discipline of a lean, capital-efficient operation; Parsons supplies the eye that makes a supplement brand feel designed rather than assembled. Pineapple is, in a sense, what happens when both sit at the same desk.
Public records place Pineapple's total funding at roughly $21.3 million, with the most recent round logged as a Series B in November 2023. The chart below shows total funding to date against the round that got it there.
Figures are approximate and drawn from public sources; investor names are not disclosed.
Pineapple begins as a two-person business hosting educational health seminars.
The seminars become online courses; the team grows to four.
Pineapple launches its first men's health products, reaching ~16 employees.
Products with unique metabolic strains arrive; the team grows to ~32.
Focus shifts to broader distribution and new markets across the portfolio.
Latest funding recorded, bringing total capital to roughly $21.3M.
Pineapple sits in the direct-to-consumer wellness market alongside brands like Ritual, Seed, Care/of and HUM Nutrition, and against the private-label and portfolio players that dominate the broader supplement aisle. What differentiates it structurally is that it competes as a builder of brands rather than a single one - closer in spirit to a brand incubator than to any one product on the shelf.
That position has trade-offs. A house of brands spreads risk across categories but demands a repeatable playbook, and Pineapple's is storytelling plus partnership plus original formulation. The company frames its ambition in terms of reach: expanding distribution and entering new markets so a growing set of brands can make a health impact for more people. It is a modest, concrete goal for a company that has never mistaken scale for the point.
Search links to founder interviews, brand stories and product walkthroughs across the web.
Before any product existed, Pineapple was a pair of people running health seminars in New York City.
Founder Brett Allcorn trained in both business (NYU Stern) and product design (Parsons).
Products you might buy can be Pineapple brands operating under their own names.
Registered in San Antonio but run remotely across North America.
It's a direct-to-consumer health supplement company that creates, markets and operates multiple consumer wellness brands under one parent, pairing original formulations with storytelling and partnerships.
Brett Allcorn is the CEO and founder. He started the company as classroom seminars in New York City and studied at NYU Stern and Parsons School of Design.
It's registered in San Antonio, Texas, and operated by a remote-first team distributed across North America; its roots are in New York City.
Its portfolio has included men's health supplements and probiotics with unique metabolic and digestive strains, sold online across multiple brands.
Public records indicate roughly $21.3M in total funding, with the most recent round recorded as a Series B in November 2023.